Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Autolus Limited
Seagen Inc.
Mayo Clinic
Corvus Pharmaceuticals, Inc.
Hoffmann-La Roche
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Medical College of Wisconsin
Mayo Clinic
Fudan University
Princess Maxima Center for Pediatric Oncology
Turning Point Therapeutics, Inc.
City of Hope Medical Center
Baylor College of Medicine
New York Medical College
Mayo Clinic
M.D. Anderson Cancer Center
Takeda
Pfizer
Universität des Saarlandes
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
City of Hope Medical Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Bristol-Myers Squibb
Washington University School of Medicine
Children's Cancer Group, China
Ohio State University Comprehensive Cancer Center
Boehringer Ingelheim
Eastern Cooperative Oncology Group
BeiGene
Ruijin Hospital
Takeda
Stanford University
Children's Oncology Group
University of Nebraska
European Organisation for Research and Treatment of Cancer - EORTC
City of Hope Medical Center
Seagen Inc.
University of Nebraska
University of Nebraska
University of Milano Bicocca
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Tessa Therapeutics